Aatmaj HealthQ3 FY23
Aatmaj Health
Q3 FY23 Earnings Call Analysis
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 2- →Target revenue for current year (FY 23-24): Around Rs. 28 to 32 crore, depending on PMJAY strategy.
- →Projected revenue in 2-3 years (FY 25-26): Around Rs. 80 to 90 crore.
- →Expected revenue for next year: Approximately Rs. 45 to 50 crore.
- →Growth driven by strategic acquisitions of multi-specialty hospitals and expansion into new verticals like IVF centers.
- →Expansion plan includes increasing bed capacity from current 330 beds to 430 beds.
- →Geographic expansion planned in four states: Gujarat, Madhya Pradesh, Rajasthan, and Maharashtra by 2027.
- →Focus on high-margin services such as IVF centers starting before the end of the current financial year.
- →Emphasis on maintaining 20% net profit margin as turnover increases, though margins may vary with scale.
Margin guidance
Category 3- →Projected turnover for current year: around Rs. 30 crore
- →Expected turnover in 2-3 years: Rs. 80 to 90 crore
- →Anticipated turnover next year (approximate): Rs. 45 to 50 crore
- →Net profit margin expected to be around 20% as turnover scales up
- →EBITDA margin currently strong at 46.7% with PAT margin at 25.9% in H1 FY '24
- →Future growth driven by strategic acquisitions, bed capacity expansion (from 330 to 430 beds), and new verticals like IVF centers
- →IVF centers anticipated to start before March 2024, expected to generate high revenue and profit
- →Operating margin expected to be maintained in future due to focused business model and cost control
- →Expansion planned in four states (Gujarat, Madhya Pradesh, Rajasthan, Maharashtra) over next 2-3 years
- →No immediate plans for further fund raising; focus on efficient management and organic growth
Sign up free to read the full earnings analysis
Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Aatmaj Health and 1,400+ other companies.
Fundraise plans
Yes- Currently, there is no immediate plan to raise further funds through debt or equity.
- The Managing Director, Dr. Tushar Suvagiya, stated that he has not thought about raising further funds at present.
- Future capital expenditure, such as for IVF centers and potential onco-radiation units, will require significant investment (around Rs. 4-5 crores for IVF centers alone).
- The company is focusing on growth through strategic acquisitions and partnerships rather than immediate fundraising.
- Any decision on future fundraising will depend on business expansion needs and capital requirements, especially for high-cost ventures like onco-radiation therapy.
(Reference: Page 7 and Page 5-6 excerpts from the transcript)
Order book
- →The transcript does not explicitly mention the current or expected order book or pending orders.
- →The focus is primarily on hospital acquisitions, expansions, and revenue projections rather than specific order books.
- →The company has recently expanded bed capacity from 130 to 330 beds, aiming for 430 beds.
- →Future growth strategies include expanding in states like Rajasthan, Madhya Pradesh, Gujarat, Maharashtra, and launching IVF centers.
- →Revenue projections for the next 2-3 years are around Rs. 80-90 crores, with a 20% net profit margin aimed.
- →No direct reference to an order book or pending orders is provided in the available transcript content.
Capex plans
Yes- →Recent CapEx was incurred to increase bed capacity from 130 to 330 beds, primarily through strategic acquisitions and leases rather than owning properties, minimizing capital outlay.
- →No plans to invest in building ownership going forward; existing newly acquired hospitals are on rental/lease agreements.
- →Planned CapEx of around ₹4-5 Cr over the next year for setting up 2 IVF centers, including equipment and operational costs.
- →IVF centers expected to start before March 2024; potential for partnership or takeover of existing centers.
- →Expansion plan includes increasing capacity to 430 beds and growing presence in Gujarat, Rajasthan, Madhya Pradesh, and Maharashtra.
- →High-capital projects like oncology radiation therapy (costing ~₹16 Cr) are currently on hold due to financial prudence.
- →No immediate plans for further fund raising for capital investments; focus is on organic growth and acquisitions.
How does Aatmaj Health rank vs peers in Healthcare Services?
Pro feature1Aatmaj Health
Rev 2Mar 3
See full Healthcare Services sector rankings
Unlock with ProWant more stocks like Aatmaj Health?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio